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Supl. Figure 1: Evaluation of  pS87 levels in the injected ventral midbrains. Western 
blot analysis shows the expression levels of total human α-syn (Sc-211) and pS87 in rat 
midbrains overexpressing human α-syn (Inj1, Inj2 and Inj3). No signal was observed in 
the non-injected hemisphere (n.inj). The evaluation of total α-syn and pS87 levels was 
performed using a standard curve based on the detection of known concentrations of 
recombinant human α-syn and pS87 α-syn (α-syn-S129A phosphorylated by CK1), 
repectively. The sepecificity of the pS87 antibody was demonstrated by the loss of signal 
when phosphorylated recombinant α-syn-S129A was incubated with Calf Intestinal 
Alkaline Phosphatse (CIAP) (Paleologou et al., 2010). 
 Supl. Fig 2: S87 mutations do not affect α-syn phosphorylation at S129. To investigate 
if S87 mutations affect α-syn phosphorylation at S129, we evaluated the level of pS129 in 
the dopaminergic neurons of animals injected with WT, S87A and S87E constructs. (A) 
Confocal imaging illustrates the expression levels of human α-syn (red) and pS129 
(green) in the injected SN. Scale bar=100 µm (B) Histogram illustrating the relative 
levels of pS129/total α-syn ratio. pS129 and total α-syn levels were quantified in 
individual neurons using ImageJ software as previously described by Ramonet and 
collaborators (Ramonet et al., 2011). The quantification of the ratio of fluorescence 
intensity pS129/total human α-syn did not reveal any significant difference between cells 
overexpressed each of the S87-mutated α-syn constructs. 
  
Supl. Fig 3: S87 mutations do not affect human α-syn sub-cellular localization. 
Confocal imaging of Tyrosine Hydroxylase (TH) (green) and human α-syn (red) 
immunofluorescence in the injected SN, revealing a similar sub-cellular localization of 
Syn WT and S87 mutants in the cytosolic and nuclear compartments of infected neurons. 
Scale bar=10µm 
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